Publication | Closed Access

Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course

Homologous Recombination DeficiencyTumor HeterogeneityMolecular SubtypeMedicinePathologyGynecologyIntratumor HeterogeneityCancer GeneticsOncologyGynecology OncologyTumor BiologyOvarian Cancer